ANALISIS KINERJA KEUANGAN PERUSAHAAN SEBELUM DAN SETELAH PANDEMI COVID-19

ICA BRILIAN NOVI PUTRI, 12406193010 (2023) ANALISIS KINERJA KEUANGAN PERUSAHAAN SEBELUM DAN SETELAH PANDEMI COVID-19. [ Skripsi ]

Text ANALISIS KINERJA KEUANGAN PERUSAHAAN SEBELUM DAN SETELAH PANDEMI COVID-19.pdf Restricted to Registered users only Download (1MB)

Abstract

This study was conducted to find differences in the financial ratios of the pharmaceutical industry on the IDX for the 2018-2023 period before and after the Covid-19 outbreak. The study was conducted using financial ratios on the liquidity ratio, solvency ratio, and profitability ratio. In the liquidity ratio, measurements were used with CR and QR, for the solvency ratio it was measured using DAR and DER and in the profitability ratio using ROA measurements. All 12 pharmaceutical companies on the IDX are the population in this study. From the 12 populations, 6 company samples were selected using the purposive sampling method. Where the selection of data samples is through predetermined standards. Data testing uses the Wilcoxon signed rank test. It can be concluded that the results of the study on the liquidity ratio and solvency ratio did not change before and after the pandemic outbreak. The profitability ratio changed before and after the pandemic. Pharmaceutical companies have not been able to optimize revenue after the pandemic subsided. It is hoped that further research can add topics and expand companies from other sectors.

Actions (login required)

View Item